Sanyo Of Japan Launches Regenerative Medicine Devices
This article was originally published in PharmAsia News
Executive Summary
Japan's Sanyo Electric launched eight different devices for the field of regenerative medicine, including an automated cell culture machine. Other medical equipment includes a high-performance freezer to cool samples rapidly to minus 85 centigrade. The launches signal Sanyo's entrance into the regenerative medicine market in Japan, beyond its dominant role in making industrial freezers for hospitals. Sanyo plans to expand that area of its business to North America and Europe within the next two years. (Click here for more - a subscription may be required
You may also be interested in...
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.